Global Cord Blood (NYSE:CO) Now Covered by StockNews.com

Research analysts at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research note issued to investors on Sunday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

Shares of Global Cord Blood stock opened at $1.75 on Friday. The firm has a market cap of $212.71 million, a P/E ratio of 2.73 and a beta of 0.16. The business has a 50-day moving average price of $1.31 and a 200 day moving average price of $1.37. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.